PDE 4 inhibitors (Dainippon Sumitomo)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePDE 4 inhibitors (Dainippon Sumitomo)
Drug Alias NamePDE 4 inhibitors (Dainippon)OS-0217
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodieterase 4 inhibitors
TargetsPhosphodieterase 4
Therapy Area/IndicationsAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDainippon Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDainippon Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsAsthma

Other Information

ATC CodeN/A
Related LinksN/A